Menu

Regeneron Pharmaceuticals, Inc. (REGN)Add to comparisonRemove from comparison

Latest financial period: September 30, 2026
Filed with the SEC: October 30, 2026
Estimated earnings date: Not available

Profit #455 of 1421 companies

 Sep 26Jun 26Mar 26Dec 25
ROE/ROA68.6%68.2%70.4%71.3%

Growth #608 of 1421 companies

 Sep 26Jun 26Mar 26Dec 25
Sales andOCF growth9.3%5.0%13.0%5.3%

Payout #141 of 1421 companies

 Sep 26Jun 26Mar 26Dec 25
Shareholderdistributions/ net income60%72%62%56%

Safety #12 of 1421 companies

 BalanceStability
Equity/assets andOCF stability76.0%93.2%

Price #638 of 1421 companies

 EarningsFCF
Earnings andFCF yield$5.04$4.01